NEUSOFT XIKANG HOLDINGS INC. Financials Neusoft Xikang Holdings Inc.
Equities
9686
KYG6461A1094
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9 USD | +2.27% |
|
+2.27% | -34.31% |
| May. 02 | Neusoft Xikang's Loss Narrows in 2023 Despite Revenue Drop | MT |
| Apr. 03 | Neusoft Xikang Holdings Inc. Change of Address of Head Office and Principal Place of Business in the PRC | CI |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 1,048 |
| Enterprise Value (EV) 1 | 795.6 |
| P/E ratio | -5.46 x |
| Yield | - |
| Capitalization / Revenue | 1.95 x |
| EV / Revenue | 1.48 x |
| EV / EBITDA | -8.66 x |
| EV / FCF | -10,161,809 x |
| FCF Yield | -0% |
| Price to Book | 2.45 x |
| Nbr of stocks (in thousands) | 841,877 |
| Reference price 2 | 1.245 |
| Announcement Date | 4/29/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 503 | 614.3 | 687.4 | 537.7 |
| EBITDA 1 | -95.21 | -244.2 | -161.5 | -91.88 |
| EBIT 1 | -126.4 | -261.9 | -173.7 | -102.6 |
| Operating Margin | -25.13% | -42.63% | -25.27% | -19.08% |
| Earnings before Tax (EBT) 1 | -203 | -292.8 | -238.3 | -147.6 |
| Net income 1 | -196.4 | -296.5 | -242 | -154.7 |
| Net margin | -39.05% | -48.27% | -35.2% | -28.76% |
| EPS 2 | -0.3170 | -0.4774 | -0.3895 | -0.2279 |
| Free Cash Flow | - | 22.89 | -46.66 | -78.29 |
| FCF margin | - | 3.73% | -6.79% | -14.56% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 9/17/23 | 9/17/23 | 9/17/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 10.1 | 75.8 | 208 | - |
| Net Cash position 1 | - | - | - | 253 |
| Leverage (Debt/EBITDA) | -0.1059 x | -0.3103 x | -1.285 x | - |
| Free Cash Flow | - | 22.9 | -46.7 | -78.3 |
| ROE (net income / shareholders' equity) | - | 148% | 68.2% | 2,491% |
| ROA (Net income/ Total Assets) | - | -17.2% | -11.5% | -5.5% |
| Assets 1 | - | 1,723 | 2,097 | 2,812 |
| Book Value Per Share 2 | -0.2100 | -0.4400 | -0.7300 | 0.5100 |
| Cash Flow per Share 2 | 0.6300 | 0.5900 | 0.5600 | 0.8000 |
| Capex 1 | 107 | 18.4 | 7.34 | 4.27 |
| Capex / Sales | 21.24% | 2.99% | 1.07% | 0.79% |
| Announcement Date | 9/17/23 | 9/17/23 | 9/17/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -34.31% | 97.12M | |
| +9.22% | 33.98B | |
| +21.06% | 8.16B | |
| +32.14% | 4.26B | |
| -30.15% | 2.65B | |
| -19.11% | 1.4B | |
| -28.03% | 1.27B | |
| -33.21% | 1.17B | |
| +13.85% | 1.02B | |
| -34.50% | 917M |
- Stock Market
- Equities
- 9686 Stock
- Financials Neusoft Xikang Holdings Inc.
